Last 12 months
Inside the activity.
0 purchase rows · 9 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2018 Filed Feb 12, 2018 22:48 UTC |
Gardiner Nathaniel S.Sr. VP & General Counsel
|
Exercise / conversionCommon Stock | 4,300 | $34.70 | $149,210.00 |
DisclosureSEC source: 0001177648-18-000001 · edgar.xml · nonDerivative · entry 1 Gardiner Nathaniel S. · CIK 0001607643 · Sr. VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2017 Filed Nov 22, 2017 00:59 UTC |
Gardiner Nathaniel S.Sr. VP & General Counsel
|
GrantStock Option (right to buy) · Derivative | 21,500 | $0.00 Strike: $48.52 | $0.00 |
DisclosureSEC source: 0001177648-17-000042 · edgar.xml · derivative · entry 1 Gardiner Nathaniel S. · CIK 0001607643 · Sr. VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,500 Underlying: Common Stock · 21,500 shares Expires 2027-11-17 F1 · derivative.exercise_date: Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 17, 2017). Read SEC document |
| November 17, 2017 Filed Nov 22, 2017 00:58 UTC |
Ocain TimSenior Vice President
|
GrantStock Option (right to buy) · Derivative | 21,500 | $0.00 Strike: $48.52 | $0.00 |
DisclosureSEC source: 0001177648-17-000041 · edgar.xml · derivative · entry 1 Ocain Tim · CIK 0001599020 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,500 Underlying: Common Stock · 21,500 shares Expires 2027-11-17 F1 · derivative.exercise_date: Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 17, 2017). Read SEC document |
| November 17, 2017 Filed Nov 22, 2017 00:58 UTC |
MELLETT PAUL JTreasurer and CFO
|
GrantStock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $48.52 | $0.00 |
DisclosureSEC source: 0001177648-17-000040 · edgar.xml · derivative · entry 1 MELLETT PAUL J · CIK 0001185034 · Treasurer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2027-11-17 F1 · derivative.exercise_date: Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 17, 2017). Read SEC document |
| November 17, 2017 Filed Nov 22, 2017 00:57 UTC |
Adda NathalieSr. VP & Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 23,500 | $0.00 Strike: $48.52 | $0.00 |
DisclosureSEC source: 0001177648-17-000039 · edgar.xml · derivative · entry 1 Adda Nathalie · CIK 0001646976 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,500 Underlying: Common Stock · 23,500 shares Expires 2027-11-17 F1 · derivative.exercise_date: Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 17, 2017). Read SEC document |
| November 17, 2017 Filed Nov 22, 2017 00:56 UTC |
Or Yat SunSr. VP & CSO · 10% owner
|
GrantStock Option (right to buy) · Derivative | 23,500 | $0.00 Strike: $48.52 | $0.00 |
DisclosureSEC source: 0001177648-17-000038 · edgar.xml · derivative · entry 1 Or Yat Sun · CIK 0001571212 · Sr. VP & CSO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,500 Underlying: Common Stock · 23,500 shares Expires 2027-11-17 F1 · derivative.exercise_date: Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 17, 2017). Read SEC document |
| November 17, 2017 Filed Nov 22, 2017 00:56 UTC |
Luly Jay R.Director · President and CEO
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $48.52 | $0.00 |
DisclosureSEC source: 0001177648-17-000037 · edgar.xml · derivative · entry 1 Luly Jay R. · CIK 0001571211 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-11-17 F1 · derivative.exercise_date: Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 17, 2017). Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:07 UTC |
Peterson KristineDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $42.61 | $0.00 |
DisclosureSEC source: 0001177648-17-000033 · edgar.xml · derivative · entry 1 Peterson Kristine · CIK 0001508596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2027-09-11 F1 · derivative.exercise_date: Such option will become exercisable monthly in substantially equal installments over three years, beginning from the date of grant (September 11, 2017). Read SEC document |
| April 12, 2017 Filed Apr 14, 2017 20:14 UTC |
Or Yat SunChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 6,963 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001177648-17-000026 · edgar.xml · derivative · entry 1 Or Yat Sun · CIK 0001571212 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,963 Underlying: Common Stock · 6,963 shares Expires 2023-03-20 F1 · balance_after: On March 20, 2013, the reporting person was granted an option to purchase 41,763 shares of common stock, which becomes reportable on Form 4 only if and to the extent that the option becomes exercisable. The option becomes exercisable in up to nine installments, based on Enanta's achievement of certain clinical milestones with respect to three or more programs that progress in clinical development. This report reflects the additional shares that became exercisable upon achievement of two of the milestones. As of the date of this filing, a total of 50% of the shares subject to the option have become exercisable. Read SEC document |
| April 12, 2017 Filed Apr 14, 2017 20:13 UTC |
MELLETT PAUL JTreasurer and CFO
|
GrantStock Option (right to buy) · Derivative | 6,963 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001177648-17-000025 · edgar.xml · derivative · entry 1 MELLETT PAUL J · CIK 0001185034 · Treasurer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,963 Underlying: Common Stock · 6,963 shares Expires 2023-03-20 F1 · balance_after: On March 20, 2013, the reporting person was granted an option to purchase 41,763 shares of common stock, which becomes reportable on Form 4 only if and to the extent that the option becomes exercisable. The option becomes exercisable in up to nine installments, based on Enanta's achievement of certain clinical milestones with respect to three or more programs that progress in clinical development. This report reflects the additional shares that became exercisable upon achievement of two of the milestones. As of the date of this filing, a total of 50% of the shares subject to the option have become exercisable. Read SEC document |
| April 12, 2017 Filed Apr 14, 2017 20:13 UTC |
Luly Jay R.Director · President and CEO
|
GrantStock Option (right to buy) · Derivative | 13,925 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001177648-17-000024 · edgar.xml · derivative · entry 1 Luly Jay R. · CIK 0001571211 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,925 Underlying: Common Stock · 13,925 shares Expires 2023-03-20 F1 · balance_after: On March 20, 2013, the reporting person was granted an option to purchase 83,526 shares of common stock, which becomes reportable on Form 4 only if and to the extent that the option becomes exercisable. The option becomes exercisable in up to nine installments, based on Enanta's achievement of certain clinical milestones with respect to three or more programs that progress in clinical development. This report reflects the additional shares that became exercisable upon achievement of two of the milestones. As of the date of this filing, a total of 50% of the shares subject to the option have become exercisable. Read SEC document |
| April 11, 2017 Filed Apr 12, 2017 20:13 UTC |
MELLETT PAUL JTreasurer and CFO
|
Exercise / conversionStock Option (right to buy) · Derivative | 29,274 | $0.00 Strike: $2.97 | $0.00 |
DisclosureSEC source: 0001177648-17-000022 · edgar.xml · derivative · entry 2 MELLETT PAUL J · CIK 0001185034 · Treasurer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,274 shares Expires 2017-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
| April 11, 2017 Filed Apr 12, 2017 20:13 UTC |
MELLETT PAUL JTreasurer and CFO
|
Exercise / conversionCommon Stock | 29,274 | $2.97 | $87,057.95 |
DisclosureSEC source: 0001177648-17-000022 · edgar.xml · nonDerivative · entry 1 MELLETT PAUL J · CIK 0001185034 · Treasurer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2017 Filed Feb 22, 2017 00:46 UTC |
Russell LesleyDirector
|
GrantStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $29.02 | $0.00 |
DisclosureSEC source: 0001177648-17-000020 · edgar.xml · derivative · entry 1 Russell Lesley · CIK 0001374636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2026-11-18 F1 · derivative.exercise_date: Such option became and will become exercisable monthly in substantially equal installments over three years, beginning from November 18, 2016. Read SEC document |
| February 16, 2017 Filed Feb 22, 2017 00:42 UTC |
Vance TerryDirector
|
GrantStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $29.02 | $0.00 |
DisclosureSEC source: 0001177648-17-000018 · edgar.xml · derivative · entry 1 Vance Terry · CIK 0001572282 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2027-02-16 F1 · derivative.exercise_date: Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (February 16, 2017), with the final monthly installment vesting at the 2018 annual meeting of stockholders. Read SEC document |
| February 16, 2017 Filed Feb 22, 2017 00:39 UTC |
Golumbeski GeorgeDirector
|
GrantStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $29.02 | $0.00 |
DisclosureSEC source: 0001177648-17-000016 · edgar.xml · derivative · entry 1 Golumbeski George · CIK 0001586660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2027-02-16 F1 · derivative.exercise_date: Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (February 16, 2017), with the final monthly installment vesting at the 2018 annual meeting of stockholders. Read SEC document |
| February 16, 2017 Filed Feb 22, 2017 00:36 UTC |
CARTER BRUCE L ADirector
|
GrantStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $29.02 | $0.00 |
DisclosureSEC source: 0001177648-17-000014 · edgar.xml · derivative · entry 1 CARTER BRUCE L A · CIK 0001225503 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2027-02-16 F1 · derivative.exercise_date: Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (February 16, 2017), with the final monthly installment vesting at the 2018 annual meeting of stockholders. Read SEC document |
| February 16, 2017 Filed Feb 22, 2017 00:32 UTC |
Buckley Stephen Jr.Director
|
GrantStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $29.02 | $0.00 |
DisclosureSEC source: 0001177648-17-000012 · edgar.xml · derivative · entry 1 Buckley Stephen Jr. · CIK 0001571830 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2027-02-16 F1 · derivative.exercise_date: Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (February 16, 2017), with the final monthly installment vesting at the 2018 annual meeting of stockholders. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 22:45 UTC |
Ocain TimSenior Vice President
|
Tax withholdingCommon Stock | 830 | $29.82 | $24,746.45 |
DisclosureSEC source: 0001177648-17-000008 · edgar.xml · nonDerivative · entry 2 Ocain Tim · CIK 0001599020 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,370 F2 · shares: Represents the number of shares of common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of the PSU award. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 22:45 UTC |
Ocain TimSenior Vice President
|
GrantCommon Stock | 2,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001177648-17-000008 · edgar.xml · nonDerivative · entry 1 Ocain Tim · CIK 0001599020 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,200 F1 · shares: Represents shares of common stock issued upon vesting of a performance share unit ("PSU") award granted on February 20, 2015 as a result of the achievement of a clinical development milestone in 2016 and the settlement and issuance of those shares of common stock on Febuary 13, 2017. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 22:46 UTC |
Or Yat SunChief Scientific Officer
|
Tax withholdingCommon Stock | 1,079 | $29.82 | $32,170.39 |
DisclosureSEC source: 0001177648-17-000009 · edgar.xml · nonDerivative · entry 2 Or Yat Sun · CIK 0001571212 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,717 F2 · shares: Represents the number of shares of common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of the PSU award. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 22:46 UTC |
Or Yat SunChief Scientific Officer
|
GrantCommon Stock | 2,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001177648-17-000009 · edgar.xml · nonDerivative · entry 1 Or Yat Sun · CIK 0001571212 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,796 F1 · shares: Represents shares of common stock issued upon vesting of a performance share unit ("PSU") award granted on February 20, 2015 as a result of the achievement of a clinical development milestone in 2016 and the settlement and issuance of those shares of common stock on Febuary 13, 2017. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 22:44 UTC |
MELLETT PAUL JTreasurer and CFO
|
Tax withholdingCommon Stock | 981 | $29.82 | $29,248.52 |
DisclosureSEC source: 0001177648-17-000007 · edgar.xml · nonDerivative · entry 2 MELLETT PAUL J · CIK 0001185034 · Treasurer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,705 F2 · shares: Represents the number of shares of common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of the PSU award. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 22:44 UTC |
MELLETT PAUL JTreasurer and CFO
|
GrantCommon Stock | 2,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001177648-17-000007 · edgar.xml · nonDerivative · entry 1 MELLETT PAUL J · CIK 0001185034 · Treasurer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,686 F1 · shares: Represents shares of common stock issued upon vesting of a performance share unit ("PSU") award granted on February 20, 2015 as a result of the achievement of a clinical development milestone in 2016 and the settlement and issuance of those shares of common stock on Febuary 13, 2017. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 22:43 UTC |
Luly Jay R.Director · President and CEO
|
Tax withholdingCommon Stock | 2,278 | $29.82 | $67,918.57 |
DisclosureSEC source: 0001177648-17-000006 · edgar.xml · nonDerivative · entry 2 Luly Jay R. · CIK 0001571211 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 634,821 F2 · shares: Represents the number of shares of common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of the PSU award. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 22:43 UTC |
Luly Jay R.Director · President and CEO
|
GrantCommon Stock | 6,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001177648-17-000006 · edgar.xml · nonDerivative · entry 1 Luly Jay R. · CIK 0001571211 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 637,099 F1 · shares: Represents shares of common stock issued upon vesting of a performance share unit ("PSU") award granted on February 20, 2015 as a result of the achievement of a clinical development milestone in 2016 and the settlement and issuance of those shares of common stock on Febuary 13, 2017. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 22:41 UTC |
Gardiner Nathaniel S.Sr. VP & General Counsel
|
Tax withholdingCommon Stock | 830 | $29.82 | $24,746.45 |
DisclosureSEC source: 0001177648-17-000005 · edgar.xml · nonDerivative · entry 2 Gardiner Nathaniel S. · CIK 0001607643 · Sr. VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,270 F2 · shares: Represents the number of shares of common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of the PSU award. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 22:41 UTC |
Gardiner Nathaniel S.Sr. VP & General Counsel
|
GrantCommon Stock | 2,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001177648-17-000005 · edgar.xml · nonDerivative · entry 1 Gardiner Nathaniel S. · CIK 0001607643 · Sr. VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,100 F1 · shares: Represents shares of common stock issued upon vesting of a performance share unit ("PSU") award granted on February 20, 2015 as a result of the achievement of a clinical development milestone in 2016 and the settlement and issuance of those shares of common stock on Febuary 13, 2017. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 22:40 UTC |
Adda NathalieSr. VP & Chief Medical Officer
|
Tax withholdingCommon Stock | 792 | $29.82 | $23,613.48 |
DisclosureSEC source: 0001177648-17-000004 · edgar.xml · nonDerivative · entry 2 Adda Nathalie · CIK 0001646976 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,308 F2 · shares: Represents the number of shares of common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of the PSU award. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 22:40 UTC |
Adda NathalieSr. VP & Chief Medical Officer
|
GrantCommon Stock | 2,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001177648-17-000004 · edgar.xml · nonDerivative · entry 1 Adda Nathalie · CIK 0001646976 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,100 F1 · shares: Represents shares of common stock issued upon vesting of a performance share unit ("PSU") award granted on February 20, 2015 as a result of the achievement of a clinical development milestone in 2016 and the settlement and issuance of those shares of common stock on Febuary 13, 2017. Read SEC document |
| January 04, 2017 Filed Jan 5, 2017 21:06 UTC |
Or Yat SunChief Scientific Officer
|
SaleCommon Stock | 13,921 | $35.09 | $488,504.60 |
DisclosureSEC source: 0001177648-17-000002 · edgar.xml · nonDerivative · entry 1 Or Yat Sun · CIK 0001571212 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,876 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2016 to provide liquidity for tax payments due on account of prior option exercises. F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $35.0000 to $35.2800, inclusive. Read SEC document |
| November 29, 2016 Filed Nov 30, 2016 21:59 UTC |
Or Yat SunChief Scientific Officer
|
SaleCommon Stock | 13,921 | $31.44 | $437,609.42 |
DisclosureSEC source: 0001571212-16-000005 · edgar.xml · nonDerivative · entry 1 Or Yat Sun · CIK 0001571212 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,797 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $31.3100 to $31.5400, inclusive. Read SEC document |
| November 18, 2016 Filed Nov 23, 2016 00:11 UTC |
Gardiner Nathaniel S.Sr. VP & General Counsel
|
GrantRestricted Stock Units · Derivative | 10,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001177648-16-000031 · edgar.xml · derivative · entry 2 Gardiner Nathaniel S. · CIK 0001607643 · Sr. VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 Underlying: Common Stock · 10,500 shares Expires not disclosed F2 · derivative.exercise_price: Restricted stock units convert into shares of common stock on a one-for-one basis. F3 · derivative.exercise_date: Such restricted stock units will vest as to one half the shares on the third anniversary of the date of award (November 18, 2019) and the remainder on the fourth anniversary of the date of award (November 18, 2020). The restricted stock unit shares that vest will be issued on the first December 15 after the applicable vesting date, subject to withholding of a portion of the vested shares to satisfy tax withholding requirements. F3 · derivative.expiration_date: Such restricted stock units will vest as to one half the shares on the third anniversary of the date of award (November 18, 2019) and the remainder on the fourth anniversary of the date of award (November 18, 2020). The restricted stock unit shares that vest will be issued on the first December 15 after the applicable vesting date, subject to withholding of a portion of the vested shares to satisfy tax withholding requirements. Read SEC document |
| November 18, 2016 Filed Nov 23, 2016 00:11 UTC |
Gardiner Nathaniel S.Sr. VP & General Counsel
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $30.00 | $0.00 |
DisclosureSEC source: 0001177648-16-000031 · edgar.xml · derivative · entry 1 Gardiner Nathaniel S. · CIK 0001607643 · Sr. VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-11-18 F1 · derivative.exercise_date: Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 18, 2016). Read SEC document |
| November 18, 2016 Filed Nov 23, 2016 00:04 UTC |
Adda NathalieSr. VP & Chief Medical Officer
|
GrantRestricted Stock Units · Derivative | 10,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001177648-16-000029 · edgar.xml · derivative · entry 2 Adda Nathalie · CIK 0001646976 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 Underlying: Common Stock · 10,500 shares Expires not disclosed F2 · derivative.exercise_price: Restricted stock units convert into shares of common stock on a one-for-one basis. F3 · derivative.exercise_date: Such restricted stock units will vest as to one half the shares on the third anniversary of the date of award (November 18, 2019) and the remainder on the fourth anniversary of the date of award (November 18, 2020). The restricted stock unit shares that vest will be issued on the first December 15 after the applicable vesting date, subject to withholding of a portion of the vested shares to satisfy tax withholding requirements. F3 · derivative.expiration_date: Such restricted stock units will vest as to one half the shares on the third anniversary of the date of award (November 18, 2019) and the remainder on the fourth anniversary of the date of award (November 18, 2020). The restricted stock unit shares that vest will be issued on the first December 15 after the applicable vesting date, subject to withholding of a portion of the vested shares to satisfy tax withholding requirements. Read SEC document |
| November 18, 2016 Filed Nov 23, 2016 00:04 UTC |
Adda NathalieSr. VP & Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $30.00 | $0.00 |
DisclosureSEC source: 0001177648-16-000029 · edgar.xml · derivative · entry 1 Adda Nathalie · CIK 0001646976 · Sr. VP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2026-11-18 F1 · derivative.exercise_date: Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 18, 2016). Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 23:42 UTC |
Ocain TimSenior Vice President
|
GrantRestricted Stock Units · Derivative | 10,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001177648-16-000020 · edgar.xml · derivative · entry 2 Ocain Tim · CIK 0001599020 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 Underlying: Common Stock · 10,500 shares Expires not disclosed F2 · derivative.exercise_price: Restricted stock units convert into shares of common stock on a one-for-one basis. F3 · derivative.exercise_date: Such restricted stock units will vest as to one half the shares on the third anniversary of the date of award (November 18, 2019) and the remainder on the fourth anniversary of the date of award (November 18, 2020). The restricted stock unit shares that vest will be issued on the first December 15 after the applicable vesting date, subject to withholding of a portion of the vested shares to satisfy tax withholding requirements. F3 · derivative.expiration_date: Such restricted stock units will vest as to one half the shares on the third anniversary of the date of award (November 18, 2019) and the remainder on the fourth anniversary of the date of award (November 18, 2020). The restricted stock unit shares that vest will be issued on the first December 15 after the applicable vesting date, subject to withholding of a portion of the vested shares to satisfy tax withholding requirements. Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 23:42 UTC |
Ocain TimSenior Vice President
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $30.00 | $0.00 |
DisclosureSEC source: 0001177648-16-000020 · edgar.xml · derivative · entry 1 Ocain Tim · CIK 0001599020 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-11-18 F1 · derivative.exercise_date: Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 18, 2016). Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 23:10 UTC |
MELLETT PAUL JTreasurer and CFO
|
GrantRestricted Stock Units · Derivative | 10,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001177648-16-000014 · edgar.xml · derivative · entry 2 MELLETT PAUL J · CIK 0001185034 · Treasurer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 Underlying: Common Stock · 10,500 shares Expires not disclosed F2 · derivative.exercise_price: Restricted stock units convert into shares of common stock on a one-for-one basis. F3 · derivative.exercise_date: Such restricted stock units will vest as to one half the shares on the third anniversary of the date of award (November 18, 2019) and the remainder on the fourth anniversary of the date of award (November 18, 2020). The restricted stock unit shares that vest will be issued on the first December 15 after the applicable vesting date, subject to withholding of a portion of the vested shares to satisfy tax withholding requirements. F3 · derivative.expiration_date: Such restricted stock units will vest as to one half the shares on the third anniversary of the date of award (November 18, 2019) and the remainder on the fourth anniversary of the date of award (November 18, 2020). The restricted stock unit shares that vest will be issued on the first December 15 after the applicable vesting date, subject to withholding of a portion of the vested shares to satisfy tax withholding requirements. Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 23:10 UTC |
MELLETT PAUL JTreasurer and CFO
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $30.00 | $0.00 |
DisclosureSEC source: 0001177648-16-000014 · edgar.xml · derivative · entry 1 MELLETT PAUL J · CIK 0001185034 · Treasurer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2026-11-18 F1 · derivative.exercise_date: Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 18, 2016). Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 23:04 UTC |
Or Yat SunChief Scientific Officer · 10% owner
|
GrantRestricted Stock Units · Derivative | 10,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001177648-16-000012 · edgar.xml · derivative · entry 2 Or Yat Sun · CIK 0001571212 · Chief Scientific Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 Underlying: Common Stock · 10,500 shares Expires not disclosed F2 · derivative.exercise_price: Restricted stock units convert into shares of common stock on a one-for-one basis. F3 · derivative.exercise_date: Such restricted stock units will vest as to one half the shares on the third anniversary of the date of award (November 18, 2019) and the remainder on the fourth anniversary of the date of award (November 18, 2020). The restricted stock unit shares that vest will be issued on the first December 15 after the applicable vesting date, subject to withholding of a portion of the vested shares to satisfy tax withholding requirements. F3 · derivative.expiration_date: Such restricted stock units will vest as to one half the shares on the third anniversary of the date of award (November 18, 2019) and the remainder on the fourth anniversary of the date of award (November 18, 2020). The restricted stock unit shares that vest will be issued on the first December 15 after the applicable vesting date, subject to withholding of a portion of the vested shares to satisfy tax withholding requirements. Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 23:04 UTC |
Or Yat SunChief Scientific Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $30.00 | $0.00 |
DisclosureSEC source: 0001177648-16-000012 · edgar.xml · derivative · entry 1 Or Yat Sun · CIK 0001571212 · Chief Scientific Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2026-11-18 F1 · derivative.exercise_date: Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 18, 2016). Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 22:53 UTC |
Luly Jay R.Director · President and CEO
|
GrantRestricted Stock Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001177648-16-000008 · edgar.xml · derivative · entry 2 Luly Jay R. · CIK 0001571211 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires not disclosed F2 · derivative.exercise_price: Restricted stock units convert into shares of common stock on a one-for-one basis. F3 · derivative.exercise_date: Such restricted stock units will vest as to one half the shares on the third anniversary of the date of award (November 18, 2019) and the remainder on the fourth anniversary of the date of award (November 18, 2020). The restricted stock unit shares that vest will be issued on the first December 15 after the applicable vesting date, subject to withholding of a portion of the vested shares to satisfy tax withholding requirements. F3 · derivative.expiration_date: Such restricted stock units will vest as to one half the shares on the third anniversary of the date of award (November 18, 2019) and the remainder on the fourth anniversary of the date of award (November 18, 2020). The restricted stock unit shares that vest will be issued on the first December 15 after the applicable vesting date, subject to withholding of a portion of the vested shares to satisfy tax withholding requirements. Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 22:53 UTC |
Luly Jay R.Director · President and CEO
|
GrantStock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $30.00 | $0.00 |
DisclosureSEC source: 0001177648-16-000008 · edgar.xml · derivative · entry 1 Luly Jay R. · CIK 0001571211 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2026-11-18 F1 · derivative.exercise_date: Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 18, 2016). Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 22:44 UTC |
Russell LesleyDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $30.00 | $0.00 |
DisclosureSEC source: 0001177648-16-000005 · edgar.xml · derivative · entry 1 Russell Lesley · CIK 0001374636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2026-11-18 F1 · derivative.exercise_date: Such option will become exercisable monthly in substantially equal installments over three years, beginning from the date of grant (November 18, 2016). Read SEC document |
| September 28, 2016 Filed Sep 29, 2016 21:26 UTC |
Or Yat SunChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 3,478 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001571212-16-000002 · edgar.xml · derivative · entry 1 Or Yat Sun · CIK 0001571212 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,478 Underlying: Common Stock · 3,478 shares Expires 2023-03-20 F1 · balance_after: On March 20, 2013, the reporting person was granted an option to purchase 41,763 shares of common stock, which becomes reportable on Form 4 only if and to the extent that the option becomes exercisable. The option becomes exercisable in up to nine installments, based on Enanta's achievement of certain clinical milestones with respect to three or more programs that progress in clinical development. This report reflects the additional shares that became exercisable upon achievement of one of the milestones. As of the date of this filing, a total of 33.33% of the shares subject to the option have become exercisable. Read SEC document |
| September 28, 2016 Filed Sep 29, 2016 21:25 UTC |
MELLETT PAUL JTreasurer and CFO
|
GrantStock Option (right to buy) · Derivative | 3,478 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001185034-16-000002 · edgar.xml · derivative · entry 1 MELLETT PAUL J · CIK 0001185034 · Treasurer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,478 Underlying: Common Stock · 3,478 shares Expires 2023-03-20 F1 · balance_after: On March 20, 2013, the reporting person was granted an option to purchase 41,763 shares of common stock, which becomes reportable on Form 4 only if and to the extent that the option becomes exercisable. The option becomes exercisable in up to nine installments, based on Enanta's achievement of certain clinical milestones with respect to three or more programs that progress in clinical development. This report reflects the additional shares that became exercisable upon achievement of one of the milestones. As of the date of this filing, a total of 33.33% of the shares subject to the option have become exercisable. Read SEC document |
| September 28, 2016 Filed Sep 29, 2016 21:24 UTC |
Luly Jay R.Director · President and CEO
|
GrantStock Option (right to buy) · Derivative | 6,957 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001571211-16-000004 · edgar.xml · derivative · entry 1 Luly Jay R. · CIK 0001571211 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,957 Underlying: Common Stock · 6,957 shares Expires 2023-03-20 F1 · balance_after: On March 20, 2013, the reporting person was granted an option to purchase 83,526 shares of common stock, which becomes reportable on Form 4 only if and to the extent that the option becomes exercisable. The option becomes exercisable in up to nine installments, based on Enanta's achievement of certain clinical milestones with respect to three or more programs that progress in clinical development. This report reflects the additional shares that became exercisable upon achievement of one of the milestones. As of the date of this filing, a total of 33.33% of the shares subject to the option have become exercisable. Read SEC document |
| February 26, 2016 Filed Nov 22, 2016 23:38 UTC Amendment |
MELLETT PAUL JTreasurer and CFO
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,689 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001177648-16-000018 · edgar.xml · derivative · entry 2 MELLETT PAUL J · CIK 0001185034 · Treasurer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,689 shares Expires 2016-06-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
| February 26, 2016 Filed Nov 22, 2016 23:38 UTC Amendment |
MELLETT PAUL JTreasurer and CFO
|
Exercise / conversionCommon Stock | 6,689 | $1.29 | $8,648.88 |
DisclosureSEC source: 0001177648-16-000018 · edgar.xml · nonDerivative · entry 1 MELLETT PAUL J · CIK 0001185034 · Treasurer and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: This amendment is being filed to correct the original Form 4 filing by amending the number of securities beneficially owned following the reported transaction from "67,086" to "61,086". This amendment corrects an administrative error. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.